Latest in Lilly's weight loss drug cuts diabetes risk by 94% in three year trial, company says
Sort by
6,025 items
-
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.Business - CNBC - October 15 -
Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.Top stories - NBC News - October 16 -
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...Politics - The Hill - October 14 -
Lilly's weight loss drug shortage deemed over, but hurdles remain
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.Top stories - CBS News - October 23 -
Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial
The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.Business - MarketWatch - 5 days ago -
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in diabetes patients.Business - CNBC - October 24 -
Weight loss drugs could help patients struggling with addiction, study says
A new study shows diabetes drugs like Mounjaro and Ozempic, which people also take to lose weight, may help patients suffering from addiction. CBS News contributor Dr. Celine Gounder explains.Top stories - CBS News - October 17 -
Weight loss drugs could help with alcohol, opioid addiction, study says
Drugs like Mounjaro and Ozempic, which many use for weight loss, may also help patients suffering from addiction, according to a new study.Top stories - CBS News - October 17 -
Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales
US group revises down upper end of full-year revenue estimatesBusiness - Financial Times - October 30 -
Nurse’s death linked to approved weight-loss drug
Susan McGowan from North Lanarkshire died two weeks after taking the drug tirzepatide, brand name Mounjaro.Top stories - BBC News - Yesterday -
Weight loss drugs may help reduce drug and alcohol misuse: Research
Weight loss medications such as Ozempic may be able to cut drug and alcohol misuse in half, according to a new study from the scientific journal Addiction. The research, published Thursday, found ...Politics - The Hill - October 17 -
Will weight-loss drugs help jobless get back into work?
Ministers are lauding the new generation of weight-loss drugs - but are they really the solution?Top stories - BBC News - October 15 -
Weight-loss drugs show promise in tackling opioid and alcohol abuse
Analysis points to potential of drugs such as Ozempic beyond tackling obesity and diabetesWorld - Financial Times - October 17 -
Weight loss injections: How do drugs like Wegovy and Mounjaro work?
NHS experts report unprecedented demand for the new generation of obesity treatments.Top stories - BBC News - October 18 -
Weight-loss drugs could be key in lowering US obesity rates – experts
Medications like Ozempic ‘transformed’ diabetes care because they improved health outcomes, say experts. Obesity rates have decreased slightly in the US and while it’s too early to say whether the ...World - The Guardian - October 18 -
How will weight-loss drugs change our relationship with food?
The rise of these treatments has major implications for how we think about obesity, says James Gallagher.Top stories - BBC News - October 19 -
Weight loss drug industry injects wealth into Novo Nordisk home country
Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.Top stories - CBS News - 5 days ago -
Counterfeit weight loss drugs sold online as demand for cheaper options grows
A surge in counterfeit versions of popular weight loss drugs is raising health concerns. U.S. Customs is intercepting fake medications with potentially harmful effects. Tom Hanson reports on the ...Top stories - CBS News - Yesterday -
Counterfeit weight loss drugs feed demand for cheaper options
Record demand for Ozempic, Wegovy and other weight loss drugs is fueling a surge of dangerous knockoffs.Top stories - CBS News - Yesterday -
Weight loss jabs for jobless not dystopian, says Wes Streeting
The government is looking into whether weight-loss drugs can help get more people back to work.Top stories - BBC News - October 20 -
Maine shooting survivors claim Army negligence and FDA's weight-loss drug decision: Morning Rundown
Detroit, TCF Center, 2024 election, Harris in Pennsylvania, Lewiston Maine shooting, Trump rally shooting survivors, giant pandas at National Zoo, Mount EverestTop stories - NBC News - October 15 -
Could Weight-Loss Drugs Help Get People Back to Work? The U.K. Wants to Find Out.
The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will study the impact of a weight-loss drug on work and productivity.World - The New York Times - October 15 -
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott's continuous glucose monitor Lingo.Business - CNBC - October 15 -
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners. The pharmaceutical company behind injectable weight-loss drugs has been ...World - The Guardian - October 16 -
Weight-loss drugs may reduce opioid and alcohol abuse by up to 50%, study finds
Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...Business - MarketWatch - October 19 -
From fashion to the food industry: 11 ways that weight-loss drugs have changed the world
The growing – and sometimes secret – use of drugs containing semaglutide has had a huge impact on how we live … but where will it end?. For a phenomenon that has such visible results, there is huge ...World - The Guardian - October 20 -
Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms
Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings ...Business - MarketWatch - October 24 -
Weight Loss Jabs for Jobs?
Health Secretary says jabs could be given to help people get back into work.Top stories - BBC News - October 15 -
Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes
Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes, according to a study published Thursday in the journal ...Top stories - NBC News - October 24 -
Rapper Young Thug pleads guilty to gang, drug and gun charges almost a year after opening statements in trial
Rapper Young Thug pleads guilty to gang, drug and gun charges almost a year after opening statements in trialEntertainment - ABC News - October 31 -
-
This massive flooring company says the housing market will get better — next year
Mohawk Industries’ product mix has been hit by consumers trading down and by new construction outpacing higher-value remodeling.Business - MarketWatch - October 25 -
Eli Lilly's quarter was messy. What to do with the stock is more clear-cut
We're upgrading our rating on the drugmaker to a buy-equivalent 1.Business - CNBC - October 30